Epicrispr Biotechnologies
1
Leased
1
Closed
About
Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.
Focus
Lease
Markets
California
FAQs
Epicrispr Biotechnologies has financed 1 deal.
Epicrispr Biotechnologies's most recent deal was on April 23, 2026.
Member since: April 2026